E.O. Ospedali Galliera
Genova 16128
0 studies enrolling now · 3 studies all time
What they study most
Diamond Blackfan Anemia, Fatigue, HER-2 Positive Breast Cancer, Locally Advanced or Metastatic Breast Cancer, Metastatic Neoplasm, Myelofibrosis, Sickle Cell Disease, Thalassemia
Studies at this site
- Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast Cancer — Completed
- To Assess Efficacy and Safety of Oral Reparixin in Patients With Fatigue and Locally Advanced / Metastatic Breast Cancer — Withdrawn before enrolling
- Expanded Access of Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload — Completed